Novel Therapeutic Strategies for Ovarian Cancer Stem Cells


Novel Therapeutic Strategies for Ovarian Cancer Stem Cells

Terraneo, N.; Jacob, F.; Dubrovska, A.; Grünberg, J.

Ovarian cancer (OC) is one of the most lethal gynecologic malignancies. Due to the lack of specific symptoms and screening methods, this disease is usually diagnosed only at an advanced and metastatic stage. The gold-standard treatment for OC patients consists of debulking surgery followed by taxane combined with platinum-based chemotherapy. Most patients show complete clinical remission after first-line therapy, but the majority of them ultimately relapse, developing radio- and chemoresistant tumors. It is now proposed that the cause of recurrence and reduced therapy efficacy is the presence of small populations of cancer stem cells (CSCs). These cells are usually resistant against conventional cancer therapies and for this reason, effective targeted therapies for the complete eradication of CSCs are urgently needed. In this review article, we highlight the mechanisms of CSC therapy resistance, epithelial-to-mesenchymal transition, stemness, and novel therapeutic strategies for ovarian CSCs.

Keywords: Auger electron and alpha particle emitter; scancer stem cells; epithelial-to-mesenchymal transition; L1CAM; ovarian cancer; radioimmunotherapy; therapeutic strategies

Permalink: https://www.hzdr.de/publications/Publ-30910
Publ.-Id: 30910